The manufacturer received information alleging a dreamstation 2 advanced auto cpap contributed to hospitalization of a user.The user was hospitalized (b)(6) 2022, for atrial fibrillation which was treated with cardioversion.Cardioversion was also performed on (b)(6) 2022.The user also alleges shortness of breath, bilateral pleural effusions, and pulmonary edema.There was no report of serious patient harm or injury.Upon further investigation, the manufacturer became aware of the end user changing prescribed settings and using his wife's device instead of his own.The manufacturer discouraged this and gave recommendations to ensure proper use of device.The manufacturer's investigation is ongoing.A final report will be submitted when the manufacturer's investigation is complete.
|
The manufacturer previously reported an allegation of an issue related to sound abatement foam.Additional information was received and section b5 should be reported as: the manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information alleging an issue related to a continuous positive airway pressure (cpap) device's sound abatement foam.The patient alleged atrial fibrillation which was treated with cardioversion,shortness of breath, bilateral pleural effusions, and pulmonary edema.There was no medical intervention required by the patient.The reported event of atrial fibrillation which was treated with cardioversion,shortness of breath, bilateral pleural effusions, and pulmonary edema and its reported severity was reviewed by the manufacture's clinical expert.This event is assessed as not related to the device in this case.Based on the available information,the manufacture concludes no further action is necessary.There was no medical intervention required by the patient.The device has not yet returned to the manufacturer for evaluation.At this time, no further investigation can be performed.If any additional information is received, a follow up report will be filed.Section(s) b1, b2, has changed related to the complaint changing from the reported adverse event to a product problem.Section h1 has changed to reflect a malfunction.Section h9 has been updated in this report. section h6 health effect- impact code, type of investigation findings and investigation conclusions has been updated.
|